[DPHARMA] QoQ Cumulative Quarter Result on 31-Mar-2020 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-May-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Mar-2020 [#1]
Profit Trend
QoQ- -75.47%
YoY- -6.25%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 569,902 435,816 302,044 158,713 576,462 438,707 295,852 54.50%
PBT 76,157 55,686 37,118 17,727 70,809 56,870 37,102 61.16%
Tax -17,547 -13,269 -8,828 -4,166 -15,536 -13,630 -8,721 59.03%
NP 58,610 42,417 28,290 13,561 55,273 43,240 28,381 61.81%
-
NP to SH 58,610 42,417 28,290 13,561 55,273 43,240 28,381 61.81%
-
Tax Rate 23.04% 23.83% 23.78% 23.50% 21.94% 23.97% 23.51% -
Total Cost 511,292 393,399 273,754 145,152 521,189 395,467 267,471 53.72%
-
Net Worth 642,484 584,565 581,725 540,662 525,364 505,919 503,029 17.63%
Dividend
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Div 45,891 3,479 3,421 - 40,937 6,745 6,618 261.50%
Div Payout % 78.30% 8.20% 12.10% - 74.06% 15.60% 23.32% -
Equity
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Net Worth 642,484 584,565 581,725 540,662 525,364 505,919 503,029 17.63%
NOSH 706,026 706,026 684,383 684,383 684,383 680,106 661,881 4.37%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 10.28% 9.73% 9.37% 8.54% 9.59% 9.86% 9.59% -
ROE 9.12% 7.26% 4.86% 2.51% 10.52% 8.55% 5.64% -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 80.72 62.63 44.13 23.19 84.49 65.04 44.70 48.02%
EPS 8.46 6.16 4.13 1.98 8.25 6.49 4.26 57.66%
DPS 6.50 0.50 0.50 0.00 6.00 1.00 1.00 246.32%
NAPS 0.91 0.84 0.85 0.79 0.77 0.75 0.76 12.69%
Adjusted Per Share Value based on latest NOSH - 684,383
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 59.24 45.31 31.40 16.50 59.93 45.61 30.76 54.48%
EPS 6.09 4.41 2.94 1.41 5.75 4.50 2.95 61.77%
DPS 4.77 0.36 0.36 0.00 4.26 0.70 0.69 260.77%
NAPS 0.6679 0.6077 0.6047 0.5621 0.5461 0.5259 0.5229 17.63%
Price Multiplier on Financial Quarter End Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 -
Price 3.38 3.16 1.62 1.39 1.42 1.40 1.37 -
P/RPS 4.19 5.05 3.67 5.99 1.68 2.15 3.06 23.19%
P/EPS 40.72 51.84 39.19 70.15 17.53 21.84 31.95 17.46%
EY 2.46 1.93 2.55 1.43 5.70 4.58 3.13 -14.77%
DY 1.92 0.16 0.31 0.00 4.23 0.71 0.73 89.98%
P/NAPS 3.71 3.76 1.91 1.76 1.84 1.87 1.80 61.60%
Price Multiplier on Announcement Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 22/02/21 12/11/20 13/08/20 18/05/20 13/02/20 29/11/19 30/08/19 -
Price 3.42 4.04 3.15 1.72 1.64 1.39 1.41 -
P/RPS 4.24 6.45 7.14 7.42 1.94 2.14 3.15 21.79%
P/EPS 41.20 66.28 76.20 86.80 20.24 21.68 32.88 16.14%
EY 2.43 1.51 1.31 1.15 4.94 4.61 3.04 -13.81%
DY 1.90 0.12 0.16 0.00 3.66 0.72 0.71 92.17%
P/NAPS 3.76 4.81 3.71 2.18 2.13 1.85 1.86 59.53%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment